Changqing Zhou

2.2k total citations
64 papers, 1.6k citations indexed

About

Changqing Zhou is a scholar working on Surgery, Molecular Biology and Neurology. According to data from OpenAlex, Changqing Zhou has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 13 papers in Molecular Biology and 11 papers in Neurology. Recurrent topics in Changqing Zhou's work include Neurological disorders and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Mesenchymal stem cell research (8 papers). Changqing Zhou is often cited by papers focused on Neurological disorders and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Mesenchymal stem cell research (8 papers). Changqing Zhou collaborates with scholars based in China, United States and Singapore. Changqing Zhou's co-authors include Loren Terveen, Shashi Shekhar, Pamela Ludford, Dan Frankowski, Tong Wang, Jingfeng Wang, Zhuzhi Wen, Shaoxin Zheng, Jingying Hou and Tingting Zhong and has published in prestigious journals such as PLoS ONE, IEEE Transactions on Pattern Analysis and Machine Intelligence and International Journal of Molecular Sciences.

In The Last Decade

Changqing Zhou

60 papers receiving 1.5k citations

Peers

Changqing Zhou
Rongye Shi United States
Peng Wu China
Xi Ouyang China
Suiping Zhou Singapore
Pengyi Yang Australia
Lin Wan China
Changqing Zhou
Citations per year, relative to Changqing Zhou Changqing Zhou (= 1×) peers Masaki Ito

Countries citing papers authored by Changqing Zhou

Since Specialization
Citations

This map shows the geographic impact of Changqing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changqing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changqing Zhou more than expected).

Fields of papers citing papers by Changqing Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changqing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changqing Zhou. The network helps show where Changqing Zhou may publish in the future.

Co-authorship network of co-authors of Changqing Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Changqing Zhou. A scholar is included among the top collaborators of Changqing Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changqing Zhou. Changqing Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Shujun, Changqing Zhou, Zijie Huang, et al.. (2025). Apelin-13/APJ promotes neural stem cells to repair ischemic stroke. Tissue and Cell. 95. 102872–102872. 2 indexed citations
2.
Wu, Hao, Xiaojing Li, Shujun Yang, et al.. (2025). ELABELA promotes the migration and homing of bone marrow mesenchymal stem cells to myocardial injury sites through the ERK1/2/miR-299a-5p/Exo70 pathway. Frontiers in Pharmacology. 16. 1541869–1541869. 3 indexed citations
3.
Zhang, Qian, et al.. (2025). Efficacy and Safety of Twelve Anti‐Dyskinetic Drugs in Parkinson's Disease: A Bayesian Network Meta‐Analysis of Randomized Controlled Trials. European Journal of Neurology. 32(8). e70329–e70329. 1 indexed citations
4.
Huang, Jing, et al.. (2025). Efficacy and safety of vesicular monoamine transporter 2 inhibitors for Huntington’s disease chorea based on network meta-analysis. Frontiers in Pharmacology. 16. 1637577–1637577. 1 indexed citations
5.
Luo, Zhipeng, Gongjie Zhang, Changqing Zhou, et al.. (2024). Modeling Continuous Motion for 3D Point Cloud Object Tracking. Proceedings of the AAAI Conference on Artificial Intelligence. 38(5). 4026–4034. 3 indexed citations
6.
Yang, Shujun, Jingyu Hou, Xin Liu, et al.. (2023). Protective properties of extracellular vesicles in sepsis models: a systematic review and meta-analysis of preclinical studies. Journal of Translational Medicine. 21(1). 262–262. 10 indexed citations
7.
Zhou, Changqing, Pan Gao, & Jianlin Wang. (2023). Comprehensive Analysis of Microbiome, Metabolome, and Transcriptome Revealed the Mechanisms of Intestinal Injury in Rainbow Trout under Heat Stress. International Journal of Molecular Sciences. 24(10). 8569–8569. 18 indexed citations
8.
9.
Zhang, Qian, et al.. (2023). Pathogenic free-living amoebic encephalitis from 48 cases in China: A systematic review. Frontiers in Neurology. 14. 1100785–1100785. 10 indexed citations
10.
Zhou, Changqing, Hao Wu, Guanghui Zheng, et al.. (2023). Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway. Cellular and Molecular Neurobiology. 43(6). 2989–3003. 6 indexed citations
11.
Fu, Jiaying, Xuxiang Chen, Xin Liu, et al.. (2020). ELABELA ameliorates hypoxic/ischemic-induced bone mesenchymal stem cell apoptosis via alleviation of mitochondrial dysfunction and activation of PI3K/AKT and ERK1/2 pathways. Stem Cell Research & Therapy. 11(1). 541–541. 37 indexed citations
12.
Li, Dongliang, Lingling Liu, L. Li, et al.. (2017). Sevoflurane Induces Exaggerated and Persistent Cognitive Decline in a Type II Diabetic Rat Model by Aggregating Hippocampal Inflammation. Frontiers in Pharmacology. 8. 886–886. 29 indexed citations
13.
Hou, Jingying, Lei Wang, Huibao Long, et al.. (2017). Hypoxia preconditioning promotes cardiac stem cell survival and cardiogenic differentiation in vitro involving activation of the HIF-1α/apelin/APJ axis. Stem Cell Research & Therapy. 8(1). 215–215. 28 indexed citations
14.
Hou, Jingying, Changqing Zhou, Huibao Long, et al.. (2016). Long noncoding RNAs: Novel molecules in cardiovascular biology, disease and regeneration. Experimental and Molecular Pathology. 100(3). 493–501. 18 indexed citations
15.
Zhong, Tingting, et al.. (2015). Pioglitazone administration combined with bone marrow mesenchymal stem cells transplantation improved the heart function of rats with myocardial infarction. Zhongguo zuzhi gongcheng yanjiu yu linchuang kangfu. 19(23). 3698. 1 indexed citations
16.
Hou, Jingying, Lingyun Wang, Jinghui Hou, et al.. (2015). Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction. Stem Cell Reviews and Reports. 11(6). 885–899. 23 indexed citations
17.
Zhou, Changqing, et al.. (2014). Long‐Acting Versus Standard Non‐Ergot Dopamine Agonists in Parkinson's Disease: A Meta‐Analysis of Randomized Controlled Trials. CNS Neuroscience & Therapeutics. 20(4). 368–376. 14 indexed citations
18.
Wen, Zhuzhi, et al.. (2011). Bone marrow mesenchymal stem cells for post‐myocardial infarction cardiac repair: microRNAs as novel regulators. Journal of Cellular and Molecular Medicine. 16(4). 657–671. 67 indexed citations
19.
Wen, Zhuzhi, Shaoxin Zheng, Changqing Zhou, Jingfeng Wang, & Tong Wang. (2010). Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. Journal of Cellular and Molecular Medicine. 15(5). 1032–1043. 110 indexed citations
20.
Zhou, Changqing, Xiufeng Wang, & Li Yu. (2009). Study on law of carbon utilization of Pleurotus nebrodensis.. Zhongguo shiyongjun. 28(1). 30–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026